Efficacy of low dose capecitabine and sorafenib in patients with advanced alfa-fetoprotein secreting hepatocellular carcinoma: a 1 year experience

BACKGROUND: There is no global consensus for the optimal management of HCC. Most of patients at the time of diagnosis are not candidate for potentially curative therapy. The study aimed to evaluate the efficacy of low dose capecitabine combined with sorafenib in subset of Egyptian HCV patients prese...

Descripción completa

Detalles Bibliográficos
Autor principal: Hanafy, Amr Shaaban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040661/
https://www.ncbi.nlm.nih.gov/pubmed/27733977
http://dx.doi.org/10.1186/s40064-016-3376-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040661/
https://www.ncbi.nlm.nih.gov/pubmed/27733977
http://dx.doi.org/10.1186/s40064-016-3376-x

Ejemplares similares